Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility
31/07/2026 07:25
BRIEF-Neurizon Therapeutics Enters Strategic Research And Development Financing Facility July 31 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX:
NEURIZON ENTERS STRATEGIC RESEARCH AND DEVELOPMENT FINANCING FACILITY
EXECUTES A$17.5 MILLION RESEARCH AND DEVELOPMENT FINANCING FACILITY WITH DARE CAPITAL LOAN FUND
Further company coverage: NUZ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility